UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025329 |
|---|---|
| Receipt number | R000029136 |
| Scientific Title | Elucidating pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress and the applicability to the individualized therapy for ACO |
| Date of disclosure of the study information | 2016/12/19 |
| Last modified on | 2022/12/25 19:45:29 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Elucidating pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress and the applicability to the individualized therapy for ACO
Acronym
Elucidating pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress and the applicability to the individualized therapy for ACO
Scientific Title
Elucidating pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress and the applicability to the individualized therapy for ACO
Scientific Title:Acronym
Elucidating pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress and the applicability to the individualized therapy for ACO
Region
| Japan |
Condition
Condition
asthma COPD ovarlap:ACO,asthma,COPD
Classification by specialty
| Pneumology |
Classification by malignancy
Others
Genomic information
YES
Objectives
Narrative objectives1
The aim of this study is to elucidate the pathophysiological mechanisms of asthma COPD ovarlap(ACO) in terms of oxidative and nitrative stress, and to investigate the possibility of individualized therapy for ACO.
Basic objectives2
Others
Basic objectives -Others
observational study
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Measure and evaluate oxidative and nitrateve stress of ACO,asthma,COPD and healthy subjects.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
ACO,asthma and COPD patients diagnosed by spirometry and respiratory physician and healthy volunteers
Key exclusion criteria
patients and healthy volunteers who deny participating in this study
Target sample size
150
Research contact person
Name of lead principal investigator
| 1st name | Tomohiro |
| Middle name | |
| Last name | Ichikawa |
Organization
Tohoku University Graduate School of Medicine
Division name
Department of Respiratory Medicine
Zip code
980-8574
Address
Seiryoumachi, Aobaku, Sendai Japan
TEL
022-717-8539
ichikawa@rm.med.tohoku.ac.jp
Public contact
Name of contact person
| 1st name | Tomohiro |
| Middle name | |
| Last name | Ichikawa |
Organization
Tohoku University Graduate School of Medicine
Division name
Department of Respiratory Medicine
Zip code
980-8574
Address
Seiryoumachi, Aobaku, Sendai Japan
TEL
022-717-8539
Homepage URL
ichikawa@rm.med.tohoku.ac.jp
Sponsor or person
Institute
Department of Respiratory Medicine, Tohoku University Graduate School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Japan Society for the Promotion of Science
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Department of Respiratory Medicine
Address
2-1 Seiryoumachi, Aobaku, Sendai Japan
Tel
022-717-8007
med-kenkyo@bureau.tohoku.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
東北大学大学院医学系研究科(宮城県）
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 12 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2014 | Year | 04 | Month | 01 | Day |
Date of IRB
| 2014 | Year | 01 | Month | 27 | Day |
Anticipated trial start date
| 2014 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2026 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Human sputum cells and supernatants
Management information
Registered date
| 2016 | Year | 12 | Month | 19 | Day |
Last modified on
| 2022 | Year | 12 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029136
